<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40889953</PMID><DateCompleted><Year>2025</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2025</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2053-3624</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>2</Issue><PubDate><Year>2025</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Open heart</Title><ISOAbbreviation>Open Heart</ISOAbbreviation></Journal><ArticleTitle>Machine learning to predict high-risk coronary artery disease on CT in the SCOT-HEART trial.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e003162</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/openhrt-2025-003162</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Machine learning based on clinical characteristics has the potential to predict coronary CT angiography (CCTA) findings and help guide resource utilisation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">From the SCOT-HEART (Scottish Computed Tomography of the HEART) trial, data from 1769 patients was used to train and to test machine learning models (XGBoost, 10-fold cross validation, grid search hyperparameter selection). Two models were separately generated to predict the presence of coronary artery disease (CAD) and an increased burden of low-attenuation coronary artery plaque (LAP) using symptoms, demographic and clinical characteristics, electrocardiography and exercise tolerance testing (ETT).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Machine learning predicted the presence of CAD on CCTA (area under the curve (AUC) 0.80, 95% CI 0.74 to 0.85) better than the 10-year cardiovascular risk score alone (AUC 0.75, 95%&#x2009;CI 0.70, 0.81, p=0.004). The most important features in this model were the 10-year cardiovascular risk score, age, sex, total cholesterol and an abnormal ETT. In contrast, the second model used to predict an increased LAP burden performed similarly to the 10-year cardiovascular risk score (AUC 0.75, 95%&#x2009;CI 0.70 to 0.80 vs AUC 0.72, 95%&#x2009;CI 0.66 to 0.77, p=0.08) with the most important features being the 10-year cardiovascular risk score, age, body mass index and total and high-density lipoprotein cholesterol concentrations.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Machine learning models can improve prediction of the presence of CAD on CCTA, over the standard cardiovascular risk score. However, it was not possible to improve the prediction of an increased LAP burden based on clinical factors alone.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2025. Re-use permitted under CC BY. Published by BMJ Group.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Michelle Claire</ForeName><Initials>MC</Initials><Identifier Source="ORCID">0000-0003-3556-2428</Identifier><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK michelle.williams@ed.ac.uk.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guimaraes</LastName><ForeName>Alan R M</ForeName><Initials>ARM</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Muchen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwieci&#x144;ski</LastName><ForeName>Jacek</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Interventional Cardiology and Angiology, Institute of Cardiology, Warsaw, Poland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weir-McCall</LastName><ForeName>Jonathan R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adamson</LastName><ForeName>Philip D</ForeName><Initials>PD</Initials><Identifier Source="ORCID">0000-0002-6177-956X</Identifier><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Christchurch Heart Institute, University of Otago Christchurch, Christchurch, South Island, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mills</LastName><ForeName>Nicholas L</ForeName><Initials>NL</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roditi</LastName><ForeName>Giles H</ForeName><Initials>GH</Initials><AffiliationInfo><Affiliation>University of Glasgow, Glasgow, Glasgow, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Beek</LastName><ForeName>Edwin J R</ForeName><Initials>EJR</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicol</LastName><ForeName>Edward</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Royal Brompton and Harefield NHS Foundation Trust, London, London, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Biomedical Engineering and Imaging Sciences, King's College London, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berman</LastName><ForeName>Daniel S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Slomka</LastName><ForeName>Piotr J</ForeName><Initials>PJ</Initials><Identifier Source="ORCID">0000-0002-6110-938X</Identifier><AffiliationInfo><Affiliation>Medicine, Cedars-Sinai Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dweck</LastName><ForeName>Marc R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0009-0005-1991-0017</Identifier><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Newby</LastName><ForeName>David E</ForeName><Initials>DE</Initials><AffiliationInfo><Affiliation>British Heart Foundation Centre for Research Excellence, The University of Edinburgh, Edinburgh, Scotland, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dey</LastName><ForeName>Damini</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0003-2236-6970</Identifier><AffiliationInfo><Affiliation>Biomedical Imaging Research Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 HL148787</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL151266</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>09</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Open Heart</MedlineTA><NlmUniqueID>101631219</NlmUniqueID><ISSNLinking>2053-3624</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003324" MajorTopicYN="Y">Coronary Artery Disease</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069550" MajorTopicYN="Y">Machine Learning</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017023" MajorTopicYN="Y">Coronary Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="Y">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011237" MajorTopicYN="N">Predictive Value of Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003331" MajorTopicYN="Y">Coronary Vessels</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058226" MajorTopicYN="N">Plaque, Atherosclerotic</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Atherosclerosis</Keyword><Keyword MajorTopicYN="N">CORONARY ARTERY DISEASE</Keyword><Keyword MajorTopicYN="N">Computed Tomography Angiography</Keyword></KeywordList><CoiStatement>Competing interests: MCW has given talks for Canon Medical Systems, GE Healthcare, Siemens Healthineers, Novartis and performed consultancy for FEOPS. EN has performed consultancy for Caristo Diagnostics and FEOPS. EJRvB is supported by Scottish Imaging Network (www.sinapse.ac.uk), is on advisory board for Aidence and has given talks for AstraZeneca. He is founder/owner of QCTIS Ltd.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2025</Year><Month>7</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>0</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>9</Month><Day>2</Day><Hour>0</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>9</Month><Day>1</Day><Hour>21</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>9</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40889953</ArticleId><ArticleId IdType="pmc">PMC12406813</ArticleId><ArticleId IdType="doi">10.1136/openhrt-2025-003162</ArticleId><ArticleId IdType="pii">openhrt-2025-003162</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Knuuti J, Wijns W, Saraste A, et al. ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology (ESC) Eur Heart J. 2019;41:407&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pubmed">31504439</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Committee M, Gulati M, Levy PD, et al. AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2021;78:e187&#x2013;285.</Citation><ArticleIdList><ArticleId IdType="pubmed">34756653</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . Chest Pain of Recent Onset: Assessment and Diagnosis. NICE; 2016.</Citation></Reference><Reference><Citation>Bing R, Singh T, Dweck MR, et al. Validation of European Society of Cardiology pre-test probabilities for obstructive coronary artery disease in suspected stable angina. Eur Heart J Qual Care Clin Outcomes. 2020;6:293&#x2013;300. doi: 10.1093/ehjqcco/qcaa006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ehjqcco/qcaa006</ArticleId><ArticleId IdType="pmc">PMC7590886</ArticleId><ArticleId IdType="pubmed">31977010</ArticleId></ArticleIdList></Reference><Reference><Citation>Motwani M, Williams MC, Nieman K, et al. Great debates in cardiac computed tomography: OPINION: &#x201c;Artificial intelligence is key to the future of CCTA &#x2013; The great hope&#x201d;. J Cardiovasc Comput Tomogr. 2023;17:18&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">35945132</ArticleId></ArticleIdList></Reference><Reference><Citation>Motwani M, Dey D, Berman DS, et al. Machine learning for prediction of all-cause mortality in patients with suspected coronary artery disease: a 5-year multicentre prospective registry analysis. Eur Heart J. 2016;38:ehw188. doi: 10.1093/eurheartj/ehw188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehw188</ArticleId><ArticleId IdType="pmc">PMC5897836</ArticleId><ArticleId IdType="pubmed">27252451</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MC, Bednarski BP, Pieszko K, et al. Unsupervised learning to characterize patients with known coronary artery disease undergoing myocardial perfusion imaging. Eur J Nucl Med Mol Imaging. 2023;50:2656&#x2013;68. doi: 10.1007/s00259-023-06218-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-023-06218-z</ArticleId><ArticleId IdType="pmc">PMC10317876</ArticleId><ArticleId IdType="pubmed">37067586</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2019;Aref SJ, Maliakal G, Singh G, et al. Machine learning of clinical variables and coronary artery calcium scoring for the prediction of obstructive coronary artery disease on coronary computed tomography angiography: analysis from the CONFIRM registry. Eur Heart J. 2020;41:359&#x2013;67. doi: 10.1093/eurheartj/ehz565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehz565</ArticleId><ArticleId IdType="pmc">PMC7849944</ArticleId><ArticleId IdType="pubmed">31513271</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakanishi R, Slomka PJ, Rios R, et al. Machine Learning Adds to Clinical and CAC Assessments in Predicting 10-Year CHD and CVD Deaths. JACC Cardiovasc Imaging. 2021;14:615&#x2013;25. doi: 10.1016/j.jcmg.2020.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.08.024</ArticleId><ArticleId IdType="pmc">PMC7987201</ArticleId><ArticleId IdType="pubmed">33129741</ArticleId></ArticleIdList></Reference><Reference><Citation>Al&#x2019;Aref SJ, Singh G, Choi JW, et al. A Boosted Ensemble Algorithm for Determination of Plaque Stability in High-Risk Patients on Coronary CTA. JACC: Cardiovascular Imaging . 2020;13:2162&#x2013;73. doi: 10.1016/j.jcmg.2020.03.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2020.03.025</ArticleId><ArticleId IdType="pubmed">32682719</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams MC, Kwiecinski J, Doris M, et al. Low-Attenuation Noncalcified Plaque on Coronary Computed Tomography Angiography Predicts Myocardial Infarction: Results From the Multicenter SCOT-HEART Trial (Scottish Computed Tomography of the HEART) Circulation. 2020;141:1452&#x2013;62. doi: 10.1161/CIRCULATIONAHA.119.044720.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.119.044720</ArticleId><ArticleId IdType="pmc">PMC7195857</ArticleId><ArticleId IdType="pubmed">32174130</ArticleId></ArticleIdList></Reference><Reference><Citation>CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. The Lancet. 2015;385:2383&#x2013;91. doi: 10.1016/S0140-6736(15)60291-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)60291-4</ArticleId><ArticleId IdType="pubmed">25788230</ArticleId></ArticleIdList></Reference><Reference><Citation>Scot-Heart.Investigators ND, Adamson PD. Coronary CT Angiography and 5-Year Risk of Myocardial Infarction. N Engl J Med. 2018;379:924&#x2013;33. doi: 10.1056/NEJMoa1805971.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1805971</ArticleId><ArticleId IdType="pubmed">30145934</ArticleId></ArticleIdList></Reference><Reference><Citation>Woodward M, Brindle P, Tunstall-Pedoe H, et al. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) Heart. 2007;93:172&#x2013;6. doi: 10.1136/hrt.2006.108167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/hrt.2006.108167</ArticleId><ArticleId IdType="pmc">PMC1861393</ArticleId><ArticleId IdType="pubmed">17090561</ArticleId></ArticleIdList></Reference><Reference><Citation>Spertus JA, Winder JA, Dewhurst TA, et al. Development and evaluation of the Seattle Angina Questionnaire: a new functional status measure for coronary artery disease. J Am Coll Cardiol. 1995;25:333&#x2013;41. doi: 10.1016/0735-1097(94)00397-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0735-1097(94)00397-9</ArticleId><ArticleId IdType="pubmed">7829785</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T, Guestrin C. Xgboost: a scalable tree boosting system. Proceedings of the 22nd Acm Sigkdd International Conference on Knowledge Discovery and Data Mining; 2016. pp. 785&#x2013;94.</Citation></Reference><Reference><Citation>Williams MC, Earls JP, Hecht H. Quantitative assessment of atherosclerotic plaque, recent progress and current limitations. J Cardiovasc Comput Tomogr. 2022;16:124&#x2013;37. doi: 10.1016/j.jcct.2021.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcct.2021.07.001</ArticleId><ArticleId IdType="pubmed">34326003</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolossv&#xe1;ry M, Lin A, Kwiecinski J, et al. Coronary Plaque Radiomic Phenotypes Predict Fatal or Nonfatal Myocardial Infarction. JACC: Cardiovascular Imaging n.d.</Citation><ArticleIdList><ArticleId IdType="pubmed">39480364</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicol ED, Weir-McCall JR, Shaw LJ, et al. Great debates in cardiac computed tomography: OPINION: &#x201c;Artificial intelligence and the future of cardiovascular CT &#x2013; Managing expectation and challenging hype&#x201d;. J Cardiovasc Comput Tomogr. 2023;17:11&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">35977872</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>